We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $23.2B
1-Year Est. Return 40.19%
This Fund
S&P 500
This Quarter Est. Return
+2.46%
1 Year Est. Return
+40.19%
3 Year Est. Return
+109.35%
5 Year Est. Return
+140.11%
10 Year Est. Return
+481.97%
AUM
$59.3B
AUM Growth
+$673M
Cap. Flow
-$791M
Cap. Flow %
-1.33%
Top 10 Hldgs %
14.81%
Holding
1,919
New
237
Increased
675
Reduced
561
Closed
90

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$332M
2
OXY icon
Occidental Petroleum
OXY
+$148M
3
HAL icon
Halliburton
HAL
+$127M
4
CVS icon
CVS Health
CVS
+$73.9M
5
WAL icon
Western Alliance Bancorporation
WAL
+$70.8M

Top Sells

Rank Stock Value
1
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$520M
2
MMP
Magellan Midstream Partners, L.P.
MMP
+$194M
3
RTX icon
RTX Corp
RTX
+$107M
4
WM icon
Waste Management
WM
+$102M
5
MDLZ icon
Mondelez International
MDLZ
+$90M

Sector Composition

Rank Sector Weight
1 Healthcare 18.14%
2 Financials 15.94%
3 Technology 12.91%
4 Industrials 9.34%
5 Energy 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLGT
1751
DELISTED
Teligent, Inc
TLGT
$6K ﹤0.01%
+879
New +$7.17K
SMMCU
1752
DELISTED
South Mountain Merger Corp. Unit
SMMCU
$6K ﹤0.01%
+599
New +$5.99K
AAC
1753
DELISTED
AAC Holdings
AAC
$6K ﹤0.01%
+6,784
New +$9.51K
FMS icon
1754
Fresenius Medical Care
FMS
$12.2B
$5K ﹤0.01%
+136
New +$5.39K
ORAN
1755
DELISTED
Orange
ORAN
$5K ﹤0.01%
+337
New +$5.32K
FTSV
1756
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$5K ﹤0.01%
+454
New +$6.66K
AVEO
1757
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$5K ﹤0.01%
+745
New +$6.38K
CLSD
1758
DELISTED
Clearside Biomedical
CLSD
$4K ﹤0.01%
+278
New +$4.96K
MARK
1759
DELISTED
Remark Holdings, Inc.
MARK
$4K ﹤0.01%
+418
New +$4.91K
TTPH
1760
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$4K ﹤0.01%
+373
New +$6.86K
LUMO
1761
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$3K ﹤0.01%
+203
New +$3.07K
UPL
1762
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$2K ﹤0.01%
+10,907
New +$4.67K
BW icon
1763
Babcock & Wilcox
BW
$1.05B
$1K ﹤0.01%
+273
New +$1.05K
FCEL icon
1764
FuelCell Energy
FCEL
$1.22B
$1K ﹤0.01%
+141
New +$7.58K
HSDT icon
1765
Solana Company
HSDT
$140M
– –
0
– –
UBS icon
1766
UBS Group
UBS
$162B
$1K ﹤0.01%
+100
New +$1.23K
NMTR
1767
DELISTED
9 Meters Biopharma
NMTR
$1K ﹤0.01%
+63
New +$1.89K
SNNA
1768
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$1K ﹤0.01%
+1,238
New +$1.94K
AEIS icon
1769
Advanced Energy
AEIS
$10.2B
– –
-25,700
Closed -$1.28M
AGI icon
1770
Alamos Gold
AGI
$14.9B
– –
-113
Closed -$1K
ARLO icon
1771
Arlo Technologies
ARLO
$1.48B
– –
-952,643
Closed -$3.93M
ASH icon
1772
Ashland
ASH
$3.19B
– –
-9,088
Closed -$710K
BAK icon
1773
Braskem
BAK
$801M
– –
-13,400
Closed -$346K
BGC icon
1774
BGC Group
BGC
$5.78B
– –
-30,840
Closed -$164K
BLUE
1775
DELISTED
bluebird bio
BLUE
– –
-35
Closed -$72K
69 70
71
72 73

Similar funds

A
AustralianSuper Melbourne, Australia $23.1B AUM 49.74% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $23B AUM 48.97% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Macquarie Group's Q2 2019 Portfolio in Review

As of Q2 2019, Macquarie Group held 1,919 positions worth $59.3B, up 1.1% from $58.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Macquarie Group's Q2 2019 filing shows 237 new, 675 increased, 561 reduced and 90 closed positions. Its largest new stake was Ferro Corporation: 2,403,865 shares worth $38M. The largest sale was Macquarie Infrastructure Holdings, LLC, an estimated $520M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q2 2019 buy was Ferro Corporation: 2,403,865 shares worth $38M.
  • Macquarie Group added most to DuPont de Nemours in Q2 2019, an estimated $332M increase.
  • Macquarie Group's biggest Q2 2019 reduction was Macquarie Infrastructure Holdings, LLC, cutting an estimated $520M.
  • Macquarie Group fully exited Steris in Q2 2019, selling an estimated $75.7M.
  • Macquarie Group's ten largest holdings make up 15% of its $59.3B portfolio in Q2 2019.
  • Macquarie Group opened 237 new positions and closed 90 in Q2 2019.
  • Macquarie Group's portfolio value rose 1.1% quarter-over-quarter to $59.3B.

Based on Macquarie Group's 13F filing for Q2 2019, filed 14 Aug 2019.